TY - JOUR
T1 - Wearable Adaptive Resistance Training Improves Ankle Strength, Walking Efficiency and Mobility in Cerebral Palsy
T2 - A Pilot Clinical Trial
AU - Conner, Benjamin C.
AU - Remec, Nushka M.
AU - Orum, Elizabeth K.
AU - Frank, Emily M.
AU - Lerner, Zachary F.
N1 - Publisher Copyright:
© 2020 IEEE.
PY - 2020
Y1 - 2020
N2 - Goal: To determine the efficacy of wearable adaptive resistance training for rapidly improving walking ability in children with cerebral palsy (CP). Methods: Six children with spastic CP (five males, one female; mean age 14y 11mo; three hemiplegic, three diplegic; Gross Motor Function Classification System [GMFCS] levels I and II) underwent ten, 20-minute training sessions over four weeks with a wearable adaptive resistance device. Strength, speed, walking efficiency, timed up and go (TUG), and six-minute walk test (6MWT) were used to measure training outcomes. Results: Participants showed increased average plantar flexor strength (17 ± 8%, p = 0.02), increased preferred walking speed on the treadmill (39 ± 25%, p = 0.04), improved metabolic cost of transport (33 ± 9%, p = 0.03), and enhanced performance on the timed up and go (11 ± 9%, p = 0.04) and six-minute walk test (13 ± 9%, p = 0.04). Conclusions: The observed increase in preferred walking speed, reduction in metabolic cost of transport, and improved performance on clinical tests of mobility highlights the potentially transformative nature of this novel therapy; the rate at which this intervention elicited improved function was 3 - 6 times greater than what has been reported previously.
AB - Goal: To determine the efficacy of wearable adaptive resistance training for rapidly improving walking ability in children with cerebral palsy (CP). Methods: Six children with spastic CP (five males, one female; mean age 14y 11mo; three hemiplegic, three diplegic; Gross Motor Function Classification System [GMFCS] levels I and II) underwent ten, 20-minute training sessions over four weeks with a wearable adaptive resistance device. Strength, speed, walking efficiency, timed up and go (TUG), and six-minute walk test (6MWT) were used to measure training outcomes. Results: Participants showed increased average plantar flexor strength (17 ± 8%, p = 0.02), increased preferred walking speed on the treadmill (39 ± 25%, p = 0.04), improved metabolic cost of transport (33 ± 9%, p = 0.03), and enhanced performance on the timed up and go (11 ± 9%, p = 0.04) and six-minute walk test (13 ± 9%, p = 0.04). Conclusions: The observed increase in preferred walking speed, reduction in metabolic cost of transport, and improved performance on clinical tests of mobility highlights the potentially transformative nature of this novel therapy; the rate at which this intervention elicited improved function was 3 - 6 times greater than what has been reported previously.
KW - Cerebral palsy
KW - exoskeleton
KW - neurorehabilitation
KW - plantar flexor
UR - http://www.scopus.com/inward/record.url?scp=85111298961&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111298961&partnerID=8YFLogxK
U2 - 10.1109/OJEMB.2020.3035316
DO - 10.1109/OJEMB.2020.3035316
M3 - Article
AN - SCOPUS:85111298961
SN - 2644-1276
VL - 1
SP - 282
EP - 289
JO - IEEE Open Journal of Engineering in Medicine and Biology
JF - IEEE Open Journal of Engineering in Medicine and Biology
M1 - 9246668
ER -